Jyong Biotech MENS
NASDAQ MENS
$2.03 -0.02 (-0.98%)
At close: Oct 1, 2026 · 4:00 PM EDT

Jyong Biotech (MENS) Total Non-Current Liabilities (2024 - 2025)

Updated

Jyong Biotech (MENS) reported Total Non-Current Liabilities of $10.87 million for the quarter ended Dec 31, 2025, down 64.6% from $30.76 million a year earlier.

Analysis

Jyong Biotech (MENS) Total Non-Current Liabilities (2024 - 2025) Analysis & Trends

  • By year, Total Non-Current Liabilities came in at $30.76 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Jyong Biotech 155.86 Mn 155.86 Mn - 10.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 10.87 Mn
Jun 30, 2025 32.59 Mn
Dec 31, 2024 30.76 Mn
API Access

Jyong Biotech Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=MENS&period=max&api_key=YOUR_API_KEY